Sponsor
- Home
- Your Messages
-
Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
We invite you to take the "Gynecologic oncology Quiz"
Current Top Players:
1) Dr. Sandeep Chunduri
2) Dr. Hassan Ghazal
3) Dr. Amer Khouri
>> Live LeaderboardNew! PHYSICIAN REVIEW
Assess your general knowledge at the topic level with your personalized scorecard.
Thousands of multiple-choice questions pinpoint your areas of expertise and prep you for exams.
- Physician Jobs (511)
- More
- Other Specialty
Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone Journal of Clinical Oncology, 03/15/2012
Kang JH et al. – The authors found no median overall survival (OS) difference between docetaxel and irinotecan. This is the largest phase III trial comparing salvage chemotherapy (SLC) plus best supportive care (BSC) with BSC alone in advanced gastric cancer (AGC). In pretreated patients, SLC is tolerated and significantly improves OS when added to BSC.
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor